abstract a recent report that 93 per cent of invasive cervical cancers worldwide contain human papillomavirus (hpv) may be an underestimate, due to sample inadequacy or integration events affecting the hpv l1 gene, which is the target of the polymerase chain reaction (pcr)-based test which was used.